Valuation: Medpace Holdings, Inc.

Market Cap 16.69B 14.83B 13.84B 12.62B 23.8B 1,605B 24.02B 168B 64.92B 820B 62.68B 61.31B 2,633B P/E 2026 *
34x
P/E 2027 * 31.2x
Enterprise Value 15.91B 14.14B 13.2B 12.03B 22.68B 1,530B 22.9B 160B 61.88B 782B 59.75B 58.45B 2,510B EV / Sales 2026 *
5.58x
EV / Sales 2027 * 5.09x
Free-Float
80.88%
Yield 2026 *
-
Yield 2027 * -
1 day+0.95%
1 week-2.33%
Current month-3.16%
1 month+1.93%
3 months+8.40%
6 months+21.29%
Current year+7.62%
1 week 587.38
Extreme 587.385
628.69
1 month 577.64
Extreme 577.64
637.64
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
28/09/26 Sell

Chief Executive Officer

-2,410 0.0086%
24/09/26 Sell

Chief Executive Officer

-27,833 0.0997%
22/09/26 Sell

Chief Executive Officer

-49,018 0.1756%
Change 5-day change 1-year change 3-year change Capi.($)
+0.95%-2.33%+12.74%+149.20% 16.69B
+4.16%+3.04%+49.37%+94.17% 74.41B
-3.11%-3.53%+21.92%+74.60% 59.26B
+0.89%-0.63%+4.28%+34.51% 47.14B
-1.32%-4.70%+26.09%+32.89% 42.91B
+0.30%+0.85%+352.34%+689.90% 44.13B
-1.58%-2.52%+1.90%+97.06% 40.79B
-0.54%+2.93%+9.50%+50.41% 30.77B
-2.68%+5.11%+33.11%+19.50% 29.31B
-0.06%-8.01%-29.06%+327.26% 23.71B
Average -0.26%-0.94%+48.22%+156.95% 40.91B
Weighted average by Cap. -0.02%-0.53%+55.50%+149.69%

Financials

2026 *2027 *
Net sales 2.85B 2.53B 2.37B 2.16B 4.07B 274B 4.1B 28.62B 11.09B 140B 10.71B 10.48B 450B 3.03B 2.69B 2.52B 2.29B 4.32B 292B 4.36B 30.44B 11.79B 149B 11.39B 11.14B 478B
Net income 503M 447M 417M 380M 716M 48.31B 723M 5.04B 1.95B 24.7B 1.89B 1.85B 79.27B 546M 486M 453M 413M 779M 52.53B 786M 5.48B 2.13B 26.86B 2.05B 2.01B 86.19B
Net Debt -780M -693M -647M -590M -1.11B -75B -1.12B -7.83B -3.03B -38.34B -2.93B -2.87B -123B -1.24B -1.11B -1.03B -940M -1.77B -120B -1.79B -12.48B -4.84B -61.13B -4.67B -4.57B -196B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
02/10/26 $604.76 +1.12% 131,146
01/10/26 $598.08 -4.18% 233,387
30/09/26 $624.18 +0.33% 306,609
29/09/26 $622.11 +1.00% 250,692
28/09/26 $615.94 -0.48% 242,301
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
598.08USD
Average target price
589.92USD
Spread / Average Target
-1.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock